Parental Hypoglycemia Fear and Adoption of Pump Therapy in Youth with New-Onset Type 1 Diabetes (T1D)

Autor: Jonathan H. Finch, Erin M. Youngkin, Kelly R. Stanek, Susana R. Patton, Shideh Majidi, Amy E. Noser, Mark A. Clements
Rok vydání: 2018
Předmět:
Zdroj: Diabetes. 67
ISSN: 1939-327X
0012-1797
Popis: Objective: Hypoglycemia Fear (FH) is common in parents of young children with T1D and related to poor child glycemic control. We explored if T1D device adoption near onset relates to parental FH. Methods: In a prospective study of 5-9 year-olds with new onset T1D (mean age 7.4±1.3 years, mean T1D duration 4.6±3.3 months), parents completed the FH Survey at baseline (T1) and 6 (T3) and 12 (T5) months post-baseline. We recorded pump start dates for youth during the same 12 months. Results: Between T1 and T3, 44 youth (45%) initiated pump therapy. Between T3 and T5, 12 (13%) started a pump. Forty-one youth never started a pump (42%). Despite pump status, parents reported moderate FH Worry at T1 (32.2±11.2), which increased between T1 and T3 (38.0±11.3, p=0.052) and plateaued between T3 and T5 (38.4±12.3, p=0.45). There was no difference in T1 FH Worry among the 44 parents of youth who started a pump between T1 and T3 and those not on a pump. At T3, FH Worry trended higher in the 12 parents whose child started a pump between T3 and T5 than the 85 parents of youth either already on a pump or not on one (p=0.059). At T5, the 12 parents whose child started a pump between T3 and T5 reported significantly higher FH Worry than the other parents (p=0.048). Conclusions: Parents of 5-9 year-olds with new onset T1D report moderate FH in the first year of T1D. Our results suggest that initiating pump therapy may not reduce parental FH. Table.Longitudinal measures of hypoglycemia fear and relation to initiation of insulin pump therapyNT1 (Baseline)T3 (6 months)T5 (12 months)Average Age (years)977.5 ± 1.4Gender (%F)10056 (56.0%)Pump Start (%)1000 (0%)44 (44.0%)12 (12.0%)FH Worry (total)8532.7 ± 11.738.0 ± 11.338.2 ± 12.1FH Worry (pump start T1-T3)4433.1 ± 11.135.9 ± 10.738.0 ± 12.3FH Worry (pump start T3-T5)1233.3 ± 12.743.7 ± 11.644.6 ± 7.98**p value Disclosure E.M. Youngkin: None. S. Majidi: None. A. Noser: None. K.R. Stanek: None. J.H. Finch: None. M.A. Clements: Speaker's Bureau; Self; Medtronic. Advisory Panel; Self; Glooko, Inc.. S.R. Patton: None.
Databáze: OpenAIRE
Externí odkaz: